Back to
Verition Fund Management LLC
NONOVOCURE LTD
Showing 6 of 17 quarters
Position history for
Verition Fund Management LLC's holdings in NOVOCURE LTD
No. Verition Fund Management exited its NOVOCURE position in Q4 2025. Its Q3 2025 13F listed 3,000,000 shares worth $3M. Verition Fund Management already held NOVOCURE in its Q4 2021 13F, the earliest on record, and held it in 16 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$18.5M
Total Shares Change
-19.6M
Quarter-by-Quarter History